Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma

BACKGROUND: The benefits of new innovations in glioblastoma therapies should not be curtailed as a result of delays in commencement of radiation therapy, caused by clinical circumstances as well as diagnostic procedures. This study evaluates whether delays in chemo-radiotherapy after surgery, while...

Descripción completa

Detalles Bibliográficos
Autores principales: Adeberg, Sebastian, Bostel, Tilman, Harrabi, Semi, Bernhardt, Denise, Welzel, Thomas, Wick, Wolfgang, Debus, Juergen, Combs, Stephanie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518587/
https://www.ncbi.nlm.nih.gov/pubmed/26223282
http://dx.doi.org/10.1186/s12885-015-1545-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518587/
https://www.ncbi.nlm.nih.gov/pubmed/26223282
http://dx.doi.org/10.1186/s12885-015-1545-x

Ejemplares similares